Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

AbbVie (NY: ABBV )

153.43 UNCHANGED
Streaming Delayed Price Updated: 7:00 PM EDT, Sep 21, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 58
Open 153.43
Bid (Size) 152.82 (1)
Ask (Size) 153.90 (1)
Prev. Close 153.43
Today's Range 153.43 - 153.43
52wk Range 130.96 - 168.11
Shares Outstanding N/A
Dividend Yield 3.39%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
3 Bargain Stocks to Buy in a Market That's Priced for Perfection
Many stocks have nosebleed valuations. But not these. 
Via The Motley Fool
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga

Performance

YTD
-5.51%
-5.51%
1 Month
+3.50%
+3.50%
3 Month
+11.66%
+11.66%
6 Month
-1.20%
-1.20%
1 Year
+9.35%
+9.35%

More News

Read More
Only 7 Large-Cap Dividend Kings Yield Over 3%. Here's My Top Pick to Buy Now.
Via The Motley Fool
Flee to Healthcare Stocks if Recession Rears its Head?
Via MarketBeat
Topics Economy
Exposures Economy Interest Rates
This Is What Whales Are Betting On AbbVie
Via Benzinga
Here's How Much $1000 Invested In AbbVie 10 Years Ago Would Be Worth Today
Via Benzinga
AbbVie Unusual Options Activity For September 13
Via Benzinga
2 Undervalued Dividend Stocks to Buy Now
Via The Motley Fool
Former IBD 50 Stock Revance Implodes As Its 'Prestige' Plan Goes Up In Smoke
Via Investor's Business Daily
7 Safe and Steady Dividend Stocks to Buy for Volatile Time
Via InvestorPlace
The Breakthrough Therapy Aiming To Solve The World’s Mental Health Crisis
Via FinancialNewsMedia
Topics Economy
Exposures Economy Product Safety
The Top 7 Underrated Dividend Stocks Yielding 3% or More
Via InvestorPlace
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
(ABBV) - Analyzing AbbVie's Short Interest
Via Benzinga
2 Dividend Kings to Buy on the Dip and Hold Forever
Via The Motley Fool
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Why Is Immuno-Oncology Firm Harpoon Therapeutics Stock Trading Lower Today?
Via Benzinga
High Yield, Low Beta Stocks to Buy for the Next Market Meltdown
Via MarketBeat
Topics Economy Stocks
Exposures Economy Interest Rates US Equities
Another Arthritis Blockbuster Drug Faces Generic Competition: Novartis' Sandoz Inks Pact With Samsung Bioepis
Via Benzinga
Alector Announces Completion of Enrollment in the INVOKE-2 Phase 2 Clinical Trial of AL002, a TREM2 Monoclonal Antibody, in Individuals With Early Alzheimer’s Disease
From Alector, Inc.
Via GlobeNewswire
3 Biotech Stocks to Invest In for Big-Time, Long-Term Gains
Via InvestorPlace
The Truth About IPO Investing
Via Talk Markets
Topics Initial Public Offering
Exposures Securities Market
Could CVS Make a Copy of Ozempic?
Via The Motley Fool
3 No-Brainer Dividend Stocks to Buy in September
Via The Motley Fool
8 Pharma Stocks Affected by New Drug Price Negotiation Rules
Via The Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.